Dideoxycytidine toxicity on mouse hemopoietic progenitors

In Vivo. 1990 May-Jun;4(3):171-3.

Abstract

Several antiviral compounds showed a toxicity or hemopoietic progenitor cells, 2', 3' Dideoxycytidine (ddc) is the most potent drug in vitro against human T cell lymphotropic viruses and is now being tested on patients with AIDS and AIDS-related complex. We studied its toxicity on mouse hemopoietic progenitors. Results reported here show a toxic activity of ddc but further studies are required to ascertain whether this toxicity is of significance during clinical application.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow / drug effects
  • Bone Marrow / pathology
  • Colony-Forming Units Assay
  • Female
  • Hematopoiesis / drug effects
  • Hematopoietic Stem Cells / drug effects*
  • Male
  • Mice
  • Mice, Inbred DBA
  • Pancytopenia / chemically induced*
  • Zalcitabine / pharmacology
  • Zalcitabine / toxicity*

Substances

  • Zalcitabine